Preferred Drug List (PDL) Pharmacist (Any city, TX, US, 99999)

Great companies need great teams to propel their operations. Join the group that solves business challenges and enhances the way we work and grow. Working at Gainwell carries its rewards. You’ll have an incredible opportunity to grow your career in a company that values your contributions and puts a premium on work flexibility, learning, and career development. Summary As part of the Gainwell Pricing and Contracting team, the Preferred Drug List (PDL) Pharmacist supports the clinical, operational and financial PDL needs of the Medicaid Fee-for-Service line of business. This role manages the implementation, maintenance and expansion of the PDL and ensures that adjudication and related communications reflect the latest changes. The primary responsibility is the development and maintenance of a clinically appropriate and fiscally responsible PDL. Fulfilling this objective entails the following activities: monitoring drug file-related changes such as new drugs, new generics, discontinuations and their impact; developing PDL-related prior authorization criteria; identifying needed therapeutic class reviews (TCRs) and assisting with their creation and update; analyzing net cost comparisons; and monitoring Client utilization and market share trends. Additional tasks include efficiently operationalizing the program; identifying areas for improvement; and working cross-functionally to implement, update, and maintain PDL-related information in the Pharmacy Services Module. Your role in our mission Primary point of contact for the Client for all aspects of PDL maintenance, development, expansion, and transformation Provide PDL subject matter expertise to troubleshoot PDL-related matters Manage weekly meetings with Client to review clinical, operational and financial impacts to the PDL Monitor drug-related changes impacting the PDL including, but not limited to, new drugs, new generics, discontinuations, Medicaid Drug Rebate Program (MDRP) changes, price changes, drug shortages